<VariationArchive VariationID="4406" VariationName="NM_020919.4(ALS2):c.1867_1868del (p.Leu623fs)" VariationType="Deletion" Accession="VCV000004406" Version="5" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2013-10-01" MostRecentSubmission="2020-02-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19445" VariationID="4406">
      <GeneList>
        <Gene Symbol="ALS2" FullName="alsin Rho guanine nucleotide exchange factor ALS2" GeneID="57679" HGNC_ID="HGNC:443" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="201700267" stop="201780933" display_start="201700267" display_stop="201780933" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="202564985" stop="202645894" display_start="202564985" display_stop="202645894" Strand="-" />
          </Location>
          <OMIM>606352</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020919.4(ALS2):c.1867_1868del (p.Leu623fs)</Name>
      <CanonicalSPDI>NC_000002.12:201746695:AG:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q33.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="201746696" stop="201746697" display_start="201746696" display_stop="201746697" variantLength="2" positionVCF="201746695" referenceAlleleVCF="CAG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="202611419" stop="202611420" display_start="202611419" display_stop="202611420" variantLength="2" positionVCF="202611418" referenceAlleleVCF="CAG" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>c.1867_1868delCT</Name>
      </OtherNameList>
      <ProteinChange>L623fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008775.1" sequenceAccession="NG_008775" sequenceVersion="1" change="g.39476_39477del">
            <Expression>NG_008775.1:g.39476_39477del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0002152" Type="genic downstream transcript variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.202611419_202611420del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.202611419_202611420del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.201746696_201746697del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.201746696_201746697del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020919.4" sequenceAccession="NM_020919" sequenceVersion="4" change="c.1867_1868del" MANESelect="true">
            <Expression>NM_020919.4:c.1867_1868del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065970.2" sequenceAccession="NP_065970" sequenceVersion="2" change="p.Leu623fs">
            <Expression>NP_065970.2:p.Leu623fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_654" sequenceAccession="LRG_654">
            <Expression>LRG_654:g.39476_39477del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_654t1" sequenceAccession="LRG_654t1">
            <Expression>LRG_654t1:c.1867_1868del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_654p1" sequenceAccession="LRG_654p1" change="p.Leu623fs">
            <Expression>LRG_654p1:p.Leu623fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA340239" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606352.0002" DB="OMIM" />
        <XRef Type="rs" ID="386134181" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00002" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020919.4(ALS2):c.1867_1868del (p.Leu623fs) AND Juvenile primary lateral sclerosis" Accession="RCV000004656" Version="7">
        <ClassifiedConditionList TraitSetID="1213">
          <ClassifiedCondition DB="MedGen" ID="C1853396">Juvenile primary lateral sclerosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-02-10" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_020919.4(ALS2):c.1867_1868del (p.Leu623fs) AND Infantile-onset ascending hereditary spastic paralysis" Accession="RCV000995486" Version="5">
        <ClassifiedConditionList TraitSetID="1214">
          <ClassifiedCondition DB="MedGen" ID="C2931441">Infantile-onset ascending hereditary spastic paralysis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-11-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-11-12" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2013-10-01" MostRecentSubmission="2020-02-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11586297</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301421</ID>
          <ID Source="BookShelf">NBK1243</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1213" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3382" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PLS juvenile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Juvenile primary lateral sclerosis</ElementValue>
                <XRef ID="Primary+lateral+sclerosis+juvenile/5952" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011663" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">JPLS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PLSJ</ElementValue>
                <XRef Type="MIM" ID="606353" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">ALS2-related disorder involves retrograde degeneration of the upper motor neurons of the pyramidal tracts and comprises a clinical continuum of the following three phenotypes: Infantile ascending hereditary spastic paraplegia (IAHSP), characterized by onset of spasticity with increased reflexes and sustained clonus of the lower limbs within the first two years of life, progressive weakness and spasticity of the upper limbs by age seven to eight years, and wheelchair dependence in the second decade with progression toward severe spastic tetraparesis and a pseudobulbar syndrome caused by progressive cranial nerve involvement. Juvenile primary lateral sclerosis (JPLS), characterized by upper motor neuron findings of pseudobulbar palsy and spastic quadriplegia without dementia or cerebellar, extrapyramidal, or sensory signs. Juvenile amyotrophic lateral sclerosis (JALS or ALS2), characterized by onset between ages three and 20 years. All affected individuals show a spastic pseudobulbar syndrome (spasticity of speech and swallowing) together with spastic paraplegia. Some individuals are bedridden by age 12 to 50 years.</Attribute>
                <XRef ID="NBK1243" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4485" />
                <XRef ID="4485" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301421</ID>
                <ID Source="BookShelf">NBK1243</ID>
              </Citation>
              <XRef ID="247604" DB="Orphanet" />
              <XRef ID="C1853396" DB="MedGen" />
              <XRef ID="MONDO:0011663" DB="MONDO" />
              <XRef Type="MIM" ID="606353" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1214" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4157" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Autosomal Recessive Juvenile Amyotrophic Lateral Sclerosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paralysis, infantile onset ascending</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Infantile-onset ascending hereditary spastic paralysis</ElementValue>
                <XRef ID="Infantile-onset+ascending+hereditary+spastic+paralysis/3819" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011797" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IAHSP</ElementValue>
                <XRef Type="MIM" ID="607225" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">ALS2-related disorder involves retrograde degeneration of the upper motor neurons of the pyramidal tracts and comprises a clinical continuum of the following three phenotypes: Infantile ascending hereditary spastic paraplegia (IAHSP), characterized by onset of spasticity with increased reflexes and sustained clonus of the lower limbs within the first two years of life, progressive weakness and spasticity of the upper limbs by age seven to eight years, and wheelchair dependence in the second decade with progression toward severe spastic tetraparesis and a pseudobulbar syndrome caused by progressive cranial nerve involvement. Juvenile primary lateral sclerosis (JPLS), characterized by upper motor neuron findings of pseudobulbar palsy and spastic quadriplegia without dementia or cerebellar, extrapyramidal, or sensory signs. Juvenile amyotrophic lateral sclerosis (JALS or ALS2), characterized by onset between ages three and 20 years. All affected individuals show a spastic pseudobulbar syndrome (spasticity of speech and swallowing) together with spastic paraplegia. Some individuals are bedridden by age 12 to 50 years.</Attribute>
                <XRef ID="NBK1243" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4914" />
                <XRef ID="4914" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000514976" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528540" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000249543" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301421</ID>
                <ID Source="BookShelf">NBK1243</ID>
              </Citation>
              <XRef ID="293168" DB="Orphanet" />
              <XRef ID="C2931441" DB="MedGen" />
              <XRef ID="MONDO:0011797" DB="MONDO" />
              <XRef Type="MIM" ID="607225" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="99643" SubmissionDate="2013-04-30" DateLastUpdated="2013-10-01" DateCreated="2013-05-03">
        <ClinVarSubmissionID localKey="c.1867_1868delCT_NBK1243" title="c.1867_1868delCT and ALS2-Related Disorders" />
        <ClinVarAccession Accession="SCV000058591" DateUpdated="2013-10-01" DateCreated="2013-05-03" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-02-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>pathologic</GermlineClassification>
          <Comment>Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="nucleotide change">c.1867_1868delCT</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALS2-Related Disorders</ElementValue>
            </Name>
            <XRef DB="GeneReviews" ID="NBK1243" />
            <XRef DB="OMIM" ID="606353" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="24830" SubmissionDate="2020-02-21" DateLastUpdated="2020-02-24" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606352.0002_PRIMARY LATERAL SCLEROSIS, JUVENILE" title="ALS2, 2-BP DEL, 1867CT_PRIMARY LATERAL SCLEROSIS, JUVENILE" />
        <ClinVarAccession Accession="SCV000024830" DateUpdated="2020-02-24" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 affected members of a consanguineous Saudi Arabian family with juvenile primary lateral sclerosis (PLSJ; 606353), Yang et al. (2001) identified a homozygous 2-bp deletion (1867delCT) in exon 9 of the ALS2 gene. This deletion led to a frameshift and premature stop codon 23 codons after the deletion site. A deletion occurred in codon 623 for leucine and the premature stop was created at codon 646.</Attribute>
              <Citation>
                <ID Source="PubMed">11586297</ID>
              </Citation>
              <XRef DB="OMIM" ID="606353" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALS2" />
          </GeneList>
          <Name>ALS2, 2-BP DEL, 1867CT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 1867CT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606352.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PRIMARY LATERAL SCLEROSIS, JUVENILE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2267881" SubmissionDate="2020-01-21" DateLastUpdated="2020-02-03" DateCreated="2020-02-03">
        <ClinVarSubmissionID localKey="37-20200121" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001149674" DateUpdated="2020-02-03" DateCreated="2020-02-03" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München" OrgID="500240" OrganizationCategory="clinic" OrgAbbreviation="IHG-MRI-TUM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Classification criteria August 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/inodbbrd/classification_criteria.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Tissue>blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
              <FamilyData PedigreeID="274-20200121" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">274-20200121</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="C" referenceAllele="CAG" start="202611418" stop="202611420" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607225" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6902622</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2267881" TraitType="Disease" MappingType="XRef" MappingValue="607225" MappingRef="OMIM">
        <MedGen CUI="C2931441" Name="Infantile-onset ascending hereditary spastic paralysis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="99643" TraitType="Disease" MappingType="Name" MappingValue="ALS2-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="CN169291" Name="ALS2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="24830" TraitType="Disease" MappingType="Name" MappingValue="PRIMARY LATERAL SCLEROSIS, JUVENILE" MappingRef="Preferred">
        <MedGen CUI="C1853396" Name="Juvenile primary lateral sclerosis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

